Recalls / Active ingredient / Semaglutide
Semaglutide
5 FDA drug recalls involving the active ingredient “Semaglutide”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-12-19 | Class II | Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S | Novo Nordisk Inc. |
| 2025-12-19 | Class II | Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, | Novo Nordisk Inc. |
| 2025-04-09 | Class II | Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use | Cardinal Health Inc. |
| 2021-03-22 | Class II | OZEMPIC (semaglutide) injection, 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen, 1 pen, Sample. Not for Resale, Rx onl | Novo Nordisk Inc |
| 2021-03-15 | Class II | Rybelsus (semaglutide) Tablets 7 mg Once daily Each tablet contains 7 mg semaglutide 30 tablets 3 blister pack | Cardinal Health Inc. |